세계의 용해성 향상 부형제 시장 : 유형, 기능성, 투여 경로, 공급원, 제형, 용도별 - 예측(2025-2030년)
Solubility Enhancement Excipients Market by Type, Functionality, Route of Administration, Source, Form, Dosage Form, Application - Global Forecast 2025-2030
상품코드 : 1717176
리서치사 : 360iResearch
발행일 : 2025년 04월
페이지 정보 : 영문 181 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,939 ₩ 5,657,000
PDF, Excel & 1 Year Online Access (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다. 온라인 플랫폼에서 1년 동안 보고서를 무제한으로 다운로드할 수 있으며, 정기적으로 업데이트되는 정보도 이용할 수 있습니다. (연 3-4회 정도 업데이트)
US $ 4,249 ₩ 6,102,000
PDF, Excel & 1 Year Online Access (2-5 User License) help
PDF 및 Excel 보고서를 동일기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다. 온라인 플랫폼에서 1년 동안 보고서를 무제한으로 다운로드할 수 있으며, 정기적으로 업데이트되는 정보도 이용할 수 있습니다. (연 3-4회 정도 업데이트)
US $ 5,759 ₩ 8,271,000
PDF, Excel & 1 Year Online Access (Site License) help
PDF 및 Excel 보고서를 동일 기업 내 동일 지역 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다. 온라인 플랫폼에서 1년 동안 보고서를 무제한으로 다운로드할 수 있으며, 정기적으로 업데이트되는 정보도 이용할 수 있습니다. (연 3-4회 정도 업데이트)
US $ 6,969 ₩ 10,008,000
PDF, Excel & 1 Year Online Access (Enterprise User License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다. 온라인 플랫폼에서 1년 동안 보고서를 무제한으로 다운로드할 수 있으며, 정기적으로 업데이트되는 정보도 이용할 수 있습니다. (연 3-4회 정도 업데이트)


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

용해성 향상 부형제 시장은 2024년 37억 4,000만 달러, 2025년에는 CAGR 6.31%로 39억 7,000만 달러까지 성장하고, 2030년에는 54억 1,000만 달러에 달할 것으로 예측됩니다.

주요 시장 통계
기준 연도 : 2024년 37억 4,000만 달러
추정 연도 : 2025년 39억 7,000만 달러
예측 연도 : 2030년 54억 1,000만 달러
CAGR(%) 6.31%

용해도 향상 부형제는 의약품의 생체 이용률과 안정성이라는 오랜 난제를 해결하기 위해 의약품 제제에서 매우 중요한 요소로 부상하고 있습니다. 약물 전달 시스템의 급속한 혁신과 복잡성이 두드러지는 시대에 이러한 부형제는 의약품 활성 성분의 용해도를 향상시킬 뿐만 아니라 치료 제품의 전반적인 성능과 효능에 크게 기여하고 있습니다. 최근 재료 과학의 발전과 규제 기준의 진화는 부형제 개발자와 배합자가 새로운 기능성을 탐구할 수 있는 탄탄한 환경을 조성하고 있습니다.

용해도 향상 기술의 통합은 최신 의약품의 환자 결과 개선, 제조 공정 간소화, 견고한 품질 프로파일을 촉진합니다. 이 보고서에서는 부형제 시장 현황을 상세하게 조사하여 혁신적인 변화, 상세한 세분화 통찰력, 지역별 동향, 주요 산업 기업을 파악할 수 있습니다. 시장 동향 및 경쟁 전략과 함께 기술 혁신을 검증함으로써 용해도 향상 분야의 전략적 투자를 추진하고 새로운 비즈니스 기회를 포착하고자 하는 업계 이해관계자들에게 종합적인 리소스를 제공하는 것을 목표로 하고 있습니다.

이 요약은 기존 부형제 및 신규 부형제 유형에 초점을 맞추고 있으며, 의사 결정자 및 업계 전문가에게 필수적인 가이드가 될 것입니다. 다음 섹션에서는 시장의 역동적인 변화를 탐구하고 여러 세분화 매개변수에 대한 심층적인 통찰력을 제공하며 업계를 다음 단계의 성장으로 이끌기 위한 실용적인 권장사항을 제시합니다.

용해도 향상 부형제 시장의 변화

지난 몇 년 동안 용해도 향상 부형제 시장은 의약품 제제화 접근 방식을 재정의하는 혁신적인 변화를 경험했습니다. 기술 혁신과 제조 공정의 발전으로 약물 방출 프로파일을 보다 정밀하게 제어할 수 있게 되어 환자의 순응도와 효능을 향상시킬 수 있게 되었습니다. 재료과학 분야의 첨단 연구는 특히 신규 및 복잡한 제형에서 안정성을 보장하면서 용해도를 최적화할 수 있도록 조정된 부형제 개발에 중요한 역할을 하고 있습니다.

디지털 기술과 전통적인 제약 과학의 융합이 진행되고 있습니다. 실시간 공정 분석, 하이스루풋 스크리닝 방법, 계산 모델링 등의 개발은 새로운 부형제의 발견과 개발을 가속화할 뿐만 아니라 확장성과 규제 준수를 강화하고 있습니다. 이러한 개발은 보다 효율적인 파일럿에서 상업화로의 전환을 위한 길을 열어주었습니다. 혁신가들이 그린 케미스트리 원칙과 폐기물 감소 전략을 채택함에 따라 지속 가능하고 환경 친화적인 제조 공정이 주목받고 있습니다.

이와 함께, 세계 시장의 규제 프레임워크가 변화하면서 제조업체들은 더 높은 품질 기준을 채택할 수밖에 없게 되었습니다. 그 결과, 이해관계자들은 엄격한 품질 관리 조치에 대한 투자를 늘리고 국제 가이드라인에 부합하는 모범 사례를 채택하고 있습니다. 이러한 높아진 기대는 연구 기관, 수탁 제조업체 및 최종 사용자 기업 간의 협력 관계를 촉진하고 용해도 향상 부형제의 획기적인 발전을 위한 발판을 마련하고 있습니다.

용해도 향상 부형제 시장의 주요 세분화 인사이트

철저한 세분화 분석을 통해 용해도 향상 부형제 시장의 다면적인 특성이 밝혀졌으며, 현대 의약품 제형의 다양성과 복잡성을 설명하는 다양한 차원에서 해부됩니다. 유형별로 시장은 사이클로덱스트린, 친수성 고분자, 친유성 부형제, 고체 분산제, 계면활성제와 관련하여 종합적으로 조사되었습니다. 사이클로덱스트린은 α-사이클로덱스트린, β-사이클로덱스트린, γ-사이클로덱스트린으로 세분화하여 분자간 상호작용의 미묘한 이해를 가능하게 하고, 친수성 고분자는 하이드록시프로파일메틸셀룰로오스(HPMC), 폴리에틸렌글리콜(PEG), 폴리비닐알콜(PEG), 폴리비닐알코올(PEG) 폴리비닐알콜(PVA), 폴리비닐피롤리돈(PVP)과의 연관성을 분석하여 제제 과학자들이 약물 방출 메커니즘을 효과적으로 조정할 수 있도록 돕고 있습니다.

기능성 측면에서 시장은 생체이용률 향상제, 방출 조절제, 용해도 향상제, 안정화제 등 다양한 기능성을 가진 제품들로 구성되어 있으며, 각 제품들은 전체 치료 카테고리에서 최적의 약물 성능을 보장하는 데 중요한 역할을 하고 있습니다. 투여 경로는 시장을 더욱 세분화하여 주사제, 경구제, 국소제, 경피제 등 약물 전달 방식에 따라 각기 다른 제형상의 과제와 기회를 제공합니다. 천연 부형제와 합성 부형제를 구분하는 것은 원료의 지속가능성과 비용 효율성에 반영됩니다. 또한, 액상 또는 분말 제형, 흡입제, 주사제, 경구제, 외용제 등 제형에 따른 세분화는 분석의 틀을 더욱 정교하게 만들어 줍니다. 마지막으로, 화장품 및 퍼스널케어, 건강기능식품, 의약품을 포함한 용도 스펙트럼은 이러한 부형제의 광범위한 적용 가능성과 혁신적 특성을 강조하여 역동적이고 진화하는 시장 상황을 매핑합니다.

목차

제1장 서문

제2장 조사 방법

제3장 주요 요약

제4장 시장 개요

제5장 시장 인사이트

제6장 용해성 향상 부형제 시장 : 유형별

제7장 용해성 향상 부형제 시장 : 기능별

제8장 용해성 향상 부형제 시장 : 투여 경로별

제9장 용해성 향상 부형제 시장 : 소스별

제10장 용해성 향상 부형제 시장 : 형태별

제11장 용해성 향상 부형제 시장 : 제형별

제12장 용해성 향상 부형제 시장 : 용도별

제13장 아메리카의 용해성 향상 부형제 시장

제14장 아시아태평양의 용해성 향상 부형제 시장

제15장 유럽, 중동 및 아프리카의 용해성 향상 부형제 시장

제16장 경쟁 구도

기업 리스트

LSH
영문 목차

영문목차

The Solubility Enhancement Excipients Market was valued at USD 3.74 billion in 2024 and is projected to grow to USD 3.97 billion in 2025, with a CAGR of 6.31%, reaching USD 5.41 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 3.74 billion
Estimated Year [2025] USD 3.97 billion
Forecast Year [2030] USD 5.41 billion
CAGR (%) 6.31%

Solubility enhancement excipients have emerged as a pivotal element in pharmaceutical formulation, addressing longstanding challenges of drug bioavailability and stability. In an era marked by rapid innovation and increasing complexity in drug delivery systems, these excipients not only improve the solubility of active pharmaceutical ingredients but also contribute significantly to the overall performance and efficacy of therapeutic products. Recent advancements in material science, combined with evolving regulatory standards, have fostered a robust environment in which excipient developers and formulators can explore new functionalities.

The integration of solubility enhancement technologies is driving improvements in patient outcomes, streamlined manufacturing processes, and robust quality profiles for modern medicinal products. This executive summary provides an in-depth exploration of the excipients market landscape, highlighting transformative shifts, detailed segmentation insights, regional dynamics, and key industry players. By examining technical innovations alongside market trends and competitive strategies, we aim to deliver a comprehensive resource for industry stakeholders seeking to drive strategic investments and capitalize on emerging opportunities in the solubility enhancement space.

With a focus on both established and novel excipient classes, this summary serves as an essential guide for decision makers and industry experts. The following sections delve into dynamic market shifts, offer granular insights across multiple segmentation parameters, and provide actionable recommendations geared towards propelling the industry into its next phase of growth.

Transformative Shifts in the Solubility Enhancement Landscape

Over the past few years, the solubility enhancement excipients market has experienced transformative shifts that have redefined the approach to pharmaceutical formulation. Technological innovations and evolving manufacturing processes have enabled more precise control over drug release profiles, leading to improved patient compliance and efficacy. Cutting-edge research in material science has played a key role in developing tailored excipients that are capable of optimizing solubility while ensuring stability, particularly in novel and complex formulations.

The landscape is witnessing a convergence of digital technologies and traditional pharmaceutical sciences. Advances such as real-time process analytics, high-throughput screening methods, and computational modeling have not only accelerated the discovery and development of new excipient formulations but have also enhanced scalability and regulatory compliance. These developments have paved the way for more efficient pilot-to-commercial transitions. There has been a notable emphasis on sustainable and eco-friendly manufacturing processes, with innovators adopting green chemistry principles and waste reduction strategies.

In parallel, shifts in regulatory frameworks across global markets have compelled manufacturers to adopt higher quality standards. As a result, stakeholders are increasingly investing in rigorous quality control measures and adopting best practices that align with international guidelines. The raised expectations are fostering collaboration between research institutions, contract manufacturers, and end-user companies, setting the stage for groundbreaking advancements in solubility enhancement excipients.

Key Segmentation Insights in the Solubility Enhancement Excipients Market

An exhaustive segmentation analysis reveals the multifaceted nature of the solubility enhancement excipients market, dissected across various dimensions that speak to the diversity and complexity of modern pharmaceutical formulations. When viewed through the lens of type, the market is comprehensively studied in relation to cyclodextrins, hydrophilic polymers, lipophilic excipients, solid dispersion agents, and surfactants. Within cyclodextrins, further subdivisions into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin allow for a nuanced understanding of molecular interactions, while hydrophilic polymers are analyzed in context with hydroxypropyl methylcellulose (HPMC), polyethylene glycol (PEG), polyvinyl alcohol (PVA), and polyvinylpyrrolidone (PVP), enabling formulation scientists to tailor drug release mechanisms effectively.

In terms of functionality, the market spans bioavailability enhancers, release modifiers, solubility enhancers, and stabilizers, each playing a distinctive role in ensuring optimal drug performance across therapeutic categories. The route of administration further defines market segmentation, with injectable, oral, topical, and transdermal drug delivery methods each driving discreet formulation challenges and opportunities. Evaluating sources, the industry contrasts natural and synthetic excipients, a differentiation that informs the sustainability and cost-effectiveness of raw materials. Moreover, segmentation based on form-liquid versus powder-and dosage form, whether inhalation, injectable, oral, or topical formulations, further refines the analytical framework. Finally, the application spectrum, which includes cosmetics and personal care, nutraceuticals, and pharmaceuticals, underscores the broad applicability and innovative nature of these excipients, mapping a dynamic and evolving market landscape.

Based on Type, market is studied across Cyclodextrins, Hydrophilic Polymers, Lipophilic Excipients, Solid Dispersion Agents, and Surfactants. The Cyclodextrins is further studied across Alpha-cyclodextrin, Beta-cyclodextrin, and Gamma-cyclodextrin. The Hydrophilic Polymers is further studied across Hydroxypropyl methylcellulose (HPMC), PEG (Polyethylene glycol), Polyvinyl alcohol (PVA), and PVP (Polyvinylpyrrolidone). The Lipophilic Excipients is further studied across Fatty Acids, Lecithins, and Surfactants. The Solid Dispersion Agents is further studied across Maltodextrin, Mannitol, and Sorbitol.

Based on Functionality, market is studied across Bioavailability Enhancers, Release Modifiers, Solubility Enhancers, and Stabilizers.

Based on Route of Administration, market is studied across Injectable Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, and Transdermal Drug Delivery.

Based on Source, market is studied across Natural Excipients and Synthetic Excipients.

Based on Form, market is studied across Liquid and Powder.

Based on Dosage Form, market is studied across Inhalation Formulation, Injectable Formulation, Oral Formulation, and Topical Formulation.

Based on Application, market is studied across Cosmetics & Personal Care, Nutraceuticals, and Pharmaceuticals.

Regional Insights Shaping the Global Market

Regional dynamics play a crucial role in sculpting the solubility enhancement excipients market, with variations in regulatory and economic environments fostering distinct growth patterns. In the Americas, robust investments in pharmaceutical innovations and supportive healthcare policies have spurred the adoption of advanced excipient technologies, making it a key market for solubility enhancers. Regulatory agencies in this region emphasize stringent quality measures, which in turn incentivize manufacturers to invest in cutting-edge technologies that improve drug solubility and delivery systems.

Europe, Middle East & Africa have carved out a niche by emphasizing sustainability and eco-friendly technologies. Here, the integration of green chemistry principles into excipient production is supported by progressive regulatory frameworks that encourage environmental responsibility without compromising on product efficacy. Innovation hubs across these regions have cultivated collaborative networks between academic institutions and industry players, further accelerating market evolution.

The Asia-Pacific region is emerging as a formidable force in the global pharmaceutical arena due to its rapidly expanding healthcare infrastructure and large-scale manufacturing capabilities. The region benefits from considerable research and development investments, along with a burgeoning demand for both generics and innovative drugs. Such factors are instrumental in driving the adoption and development of solubility enhancement excipients, positioning Asia-Pacific as a critical contributor to overall market growth.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Prominent Players Driving Innovation in the Industry

The competitive landscape of the solubility enhancement excipients market is characterized by a mix of established multinational corporations and agile specialty companies. Industry leaders such as ABITEC Corporation, Air Liquide S.A., Ashland Global Holdings Inc., BASF SE, and Cargill, Incorporated have long been recognized for their innovative approaches to improving drug formulations. Other significant players include Clariant International Ltd., Croda International PLC, DuPont de Nemours Inc., and Evonik Industries AG, each leveraging advanced research capabilities to develop next-generation excipients.

Additional influential companies such as FMC Corporation, FREUND Corporation, and Gattefosse have made notable strides in integrating advanced material science with practical application in drug formulation. This is complemented by the strategic initiatives of IMCD Group, JRS Pharma GmbH & Co. KG, Kerry Group PLC, and Lubrizol Corporation, all of whom are proactively investing in technology to streamline the manufacturing process. Further contributions from Merck KGaA, Nippon Soda Co. Ltd., Pharma Excipients International AG, Roquette Freres SA, and Shin-Etsu Chemical Co., Ltd. reinforce the market's innovative edge. The evolving strategies of Solvay SA, SPI Pharma Inc., The DOW Chemical Company, and Wacker Chemie AG provide additional layers of technical expertise and market responsiveness, positioning them as key drivers of the global solubility enhancement excipients market.

The report delves into recent significant developments in the Solubility Enhancement Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Air Liquide S.A., Ashland Global Holdings Inc., BASF SE, Cargill, Incorporated, Clariant International Ltd., Croda International PLC, DuPont de Nemours Inc., Evonik Industries AG, FMC Corporation, FREUND Corporation, Gattefosse, IMCD Group, JRS Pharma GmbH & Co. KG, Kerry Group PLC, Lubrizol Corporation, Merck KGaA, Nippon Soda Co. Ltd., Pharma Excipients International AG, Roquette Freres SA, Shin-Etsu Chemical Co., Ltd., Solvay SA, SPI Pharma Inc., The DOW Chemical Company, and Wacker Chemie AG. Actionable Recommendations for Industry Leadership

Industry leaders are urged to adopt a proactive and strategic approach in navigating the evolving landscape of solubility enhancement excipients. First, investing in research and development is paramount. Companies should prioritize innovations that not only address immediate formulation challenges but also anticipate regulatory demands and future therapeutic trends. A sustained commitment to R&D will aid in the development of novel excipient classes that can significantly boost drug performance and patient compliance.

Furthermore, collaboration across the supply chain-from raw material providers to end users-is essential. Cross-industry partnerships and alliances can accelerate technology transfer, reduce time-to-market, and enhance the overall quality of final products. This integrated approach not only fosters technological synergy but also nurtures a collaborative environment where best practices are shared and standardized.

Industry leaders should also diversify their portfolio strategies by engaging in targeted segmentation efforts. By aligning offerings with specific functionalities, routes of administration, and application areas, companies can optimize their market presence and mitigate risks associated with market fluctuations. Embracing digital transformation and advanced analytics to monitor market trends in real time will further empower organizations to make informed strategic decisions. These actionable recommendations are designed to position companies at the forefront of industry innovation and sustainability, ensuring they remain competitive in a rapidly evolving marketplace.

Conclusion and Forward-Looking Perspectives

The investigation into solubility enhancement excipients reflects a market on the brink of significant evolution. With the convergence of advanced material science, digital technologies, and innovative manufacturing processes, the market is set to redefine pharmaceutical formulation paradigms. The continuous pursuit of higher quality excipients, driven by both improved bioavailability and enhanced patient outcomes, underscores the importance of this field in modern pharmaceutical development.

The insights discussed in this summary demonstrate the necessity for a dynamic and adaptable approach to product development, one that leverages cross-functional expertise and embraces evolving industry standards. As regulatory bodies around the world tighten quality standards and promote sustainable practices, companies are increasingly compelled to refine their strategies and invest in breakthrough technologies.

Looking ahead, the role of solubility enhancement excipients will undoubtedly expand, offering new avenues for innovation and market growth. Stakeholders are encouraged to remain agile, continuously monitor competitive landscapes, and invest in the technical advancements that drive tomorrow's pharmaceutical breakthroughs.

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Solubility Enhancement Excipients Market, by Type

7. Solubility Enhancement Excipients Market, by Functionality

8. Solubility Enhancement Excipients Market, by Route of Administration

9. Solubility Enhancement Excipients Market, by Source

10. Solubility Enhancement Excipients Market, by Form

11. Solubility Enhancement Excipients Market, by Dosage Form

12. Solubility Enhancement Excipients Market, by Application

13. Americas Solubility Enhancement Excipients Market

14. Asia-Pacific Solubility Enhancement Excipients Market

15. Europe, Middle East & Africa Solubility Enhancement Excipients Market

16. Competitive Landscape

Companies Mentioned

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기